Emerging Antitrust Issues Amid the COVID-19 Pandemic: What Companies and Financial Institutions Must Know and Do

Dr. Robert Kneuper is an Expert Economist at Info Tech, Inc. and has a Ph.D. in Applied Economics from Clemson University.  Dr. Kneuper also serves as an adjunct professor at Charleston Southern University, where he teaches courses in managerial economics and corporate finance. Dr. Kneuper also has taught antitrust economics at Loyola University Chicago School of Law.

Dr. Kneuper spent over 10 years analyzing antitrust matters at the FTC where he worked extensively on a wide variety of antitrust matters. As a consultant, Dr. Kneuper has worked on numerous antitrust class action cases including price fixing cases and “pay for delay” cases.

Dr. Kneuper consults on a wide variety of applied economic and applied finance topics such as antitrust, damages, class certification, intellectual property, and regulation.  His work spans a wide variety of industries including financial markets, health care, pharmaceuticals, insurance, energy, media, entertainment, transportation, real estate, internet, sports, gaming, aerospace, defense, waste collection, retail and consumer products.

Vikram Kapoor is a Senior Managing Director at Ankura, based in New York. Mr. Kapoor has over fifteen years of experience in litigation consulting helping manage large expert and consulting engagements involving complex econometrics, valuation and quantitative finance.

Mr. Kapoor has submitted expert reports and testified in U.S. Federal Court, U.S. State Court, U.S. FINRA arbitration, Singapore International Commercial Court and Stockholm District Court. Mr. Kapoor has also submitted reports/white papers in regulatory investigations and whistle blower allegations.

Mr. Kapoor has and continues to work with dealer banks in LIBOR-based and other OTC product and related derivatives antitrust class action litigations. In this regard, he has analyzed large volumes of trade data related to credit, interest rate and foreign exchange derivative products. The data spans more than ten years and includes trade-by-trade data and bid-ask spread data produced by DTCC, Markit and individual dealer defendants.  Mr. Kapoor is also active in matters related to LIBOR transition.

Hesh Parlikad represents companies and financial institutions in all phases of litigation, including trial, arbitration, and appellate proceedings. His practice focuses on disputes involving complex financial products and securities, and he has litigated and tried novel disputes arising out of the Lehman bankruptcy concerning derivatives governed by ISDA documentation. He also has represented financial institutions in antitrust litigation concerning financial derivatives.

Hesh serves as the chair for Diversity, Inclusion & Advancement in Jones Day's New York Office. He served as president of the South Asian Bar Association of New York in 2017 and continues to serve on its Private Sector Steering Committee, comprised of law firm partners and in-house counsel from the Greater New York City Area.

Aaron Healey is a litigator and trial lawyer representing clients in complex commercial litigation with an emphasis on antitrust matters. He represents clients in a wide range of industries, including health care services and pharmaceuticals, consumer products, airlines, railroads, defense technologies, and gaming.

Aaron has defended several mergers from antitrust challenges, including the successful defenses of STERIS Corporation's acquisition of Synergy Health against a challenge brought by the FTC and Cabell Huntington Hospital's acquisition of St. Mary's Medical Center from a challenge also brought by the FTC. He represented Aetna in its acquisition of Humana from a challenge brought by the DOJ.